コンテンツへスキップ
Merck
  • MicroRNA-92a upholds Bmp signaling by targeting noggin3 during pharyngeal cartilage formation.

MicroRNA-92a upholds Bmp signaling by targeting noggin3 during pharyngeal cartilage formation.

Developmental cell (2013-02-16)
Guozhu Ning, Xiuli Liu, Miaomiao Dai, Anming Meng, Qiang Wang
要旨

Craniofacial malformations are common structural birth defects and usually associate with abnormal development of pharyngeal arches. Although some microRNAs have been found to be implicated in chondrogenesis in vitro, few have been shown to be essential for cartilage and bone development at the whole organism level. In this study, we report that mir92a is highly enriched in the chondrogenic progenitors and that its inactivation results in loss of pharyngeal cartilage elements due to poor proliferation, impaired differentiation, and unsustainable survival of chondrogenic progenitors. The Bmp antagonist gene noggin3 (nog3) is a direct target of mir92a. Inactivation of mir92a stabilizes nog3 mRNA, leading to repression of Bmp signaling and abnormal behaviors of chondrogenic progenitors. In contrast, ectopic expression of mir92a duplex decreases nog3 mRNA levels and, as a result, derepresses Bmp signaling and promotes cell apoptosis. Therefore, mir92a acts to maintain Bmp activity during pharyngeal cartilage formation by targeting nog3.

材料
製品番号
ブランド
製品内容

Roche
In Situ細胞死検出キット、TMRレッド, sufficient for ≤50 tests
現在、価格および在庫状況を閲覧できません。
Sigma-Aldrich
6-[4-(2-ピペリジン-1-イルエトキシ)フェニル]-3-ピリジン-4-イルピラゾロ[1,5-a]ピリミジン, ≥98% (HPLC)
現在、価格および在庫状況を閲覧できません。
Roche
抗ジゴキシゲニン‐POD(poly)、Fabフラグメント, from sheep
現在、価格および在庫状況を閲覧できません。
Roche
抗フルオレセイン-POD、Fabフラグメント, from sheep
現在、価格および在庫状況を閲覧できません。
Sigma-Aldrich
モノクロナール抗BrdU マウス宿主抗体, clone BU-33, ascites fluid, Immunohistology Grade
現在、価格および在庫状況を閲覧できません。